Lorantis' Other Investors

Lorantis raised a round of funding on , . Investors include Abingworth.

Lorantis is discovering and developing breakthrough products for the treatment of immunological and inflammatory diseases based on antigen-specific tolerance. The company's approach arises from the di…

Articles about Lorantis' Other Investors: